Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

Last updated: January 27, 2025 7:24 am

0 Min Read

MedPage Today) — In this exclusive MedPage Today video, Virginia Kaklamani, MD, DSc, of UT Health Sciences Center in San Antonio and co-director of the San Antonio Breast Cancer Symposium (SABCS), discusses a subgroup analysis of the phase III…

Leave a Reply Cancel reply

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

Refresh Screen

Ads Blocker Detected & This Is Prohibited!!!

Refresh Screen

Top Stories

Advancing stroke imaging analysis with interpretable AI and effective connectivity models

Leeds United consider Daniel Farke sack despite promotion

Why Parker replacing Postecoglou at Spurs would be ridiculous

Stay Connected

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

Leave a Reply Cancel reply

Related Stories

Advancing stroke imaging analysis with interpretable AI and effective connectivity models

Omalizumab treats multi-food allergy better than oral immunotherapy, study finds

Sleep apnea linked to increased risk of Parkinson’s: Study suggests CPAP may reduce risk

Can making the NHS cleaner slow the spread of disease?

Today’s letters: Call to revive the ByWard Market strikes a chord

Public servant loses legal bid to work from home due to COVID policy

Autoimmune diseases misdiagnosed as psychosomatic can lead to long-term damage to physical and mental well-being

‘I’ve found the best 5 midi dresses for spring at Finery London and they’re all under £50’